Want to see IN:SPARC full AI Analyst Report?
Sun Pharma Advanced Research Co. Ltd. (SPARC) Financial Statements
Sun Pharma Advanced Research Co. Ltd. Financial Overview
Sun Pharma Advanced Research Co. Ltd.'s market cap is currently $57.41B. The company's EPS TTM is $48.81; its P/E ratio is 3.60; Sun Pharma Advanced Research Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.79B | $ 717.70M | $ 755.45M | $ 2.39B | $ 1.37B |
| Gross Profit | $ 17.27B | $ 486.50M | $ -1.24B | $ 821.21M | $ 105.52M |
| Operating Income | $ 15.89B | $ -2.78B | $ -4.12B | $ -2.24B | $ -1.97B |
| EBITDA | $ 15.99B | $ -3.23B | $ -3.73B | $ -2.03B | $ -1.80B |
| Net Income | $ 15.53B | $ -3.43B | $ -3.87B | $ -2.23B | $ -2.03B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 26.20M | $ 19.60M | $ 1.57B | $ 4.07B | $ 128.89M |
| Total Assets | $ 21.71B | $ 3.36B | $ 5.15B | $ 8.30B | $ 2.80B |
| Total Debt | $ 5.59B | $ 2.69B | $ 611.51M | $ 156.70M | $ 792.14M |
| Net Debt | $ 5.58B | $ 2.67B | $ 558.22M | $ 150.90M | $ 779.89M |
| Total Liabilities | $ 8.32B | $ 5.52B | $ 3.89B | $ 3.17B | $ 2.49B |
| Stockholders' Equity | $ 13.39B | $ -2.17B | $ 1.26B | $ 5.13B | $ 312.26M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.97B | $ -3.71B | $ -4.56B | $ -845.10M | $ -2.41B |
| Operating Cash Flow | $ -2.73B | $ -3.60B | $ -4.29B | $ -691.20M | $ -2.08B |
| Investing Cash Flow | $ -235.30M | $ 1.58B | $ 3.92B | $ -5.48B | $ -291.67M |
| Financing Cash Flow | $ 2.96B | $ 1.99B | $ 424.05M | $ 6.17B | $ 2.29B |
Currency in INR
